GeneFirst

About:

GeneFirst is a molecular diagnostics company working in the fields of infectious disease, cancer diagnostics, and personalized medicine.

Website: https://www.genefirst.com/

Twitter/X: genefirst

Top Investors: EASME - EU Executive Agency for SMEs

Description:

GeneFirst is a molecular diagnostics company working predominantly in the fields of infectious disease, cancer diagnostics and personalized medicine. GeneFirst offers robust easy-to-use, sensitive, and affordable molecular diagnostics technologies and products to researchers, clinicians, and drug companies to enable accurate diagnosis and the delivery of safe and effective medicines. Its patented technologies allow for simultaneous detection of multiple targets in one reaction.

Total Funding Amount:

2.92M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Abingdon, Oxfordshire, United Kingdom

Founded Date:

2011-01-01

Contact Email:

info(AT)genefirst.com

Founders:

Guoliang Fu

Number of Employees:

11-50

Last Funding Date:

2017-11-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai